583031-89-4Relevant academic research and scientific papers
LIQUID PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDE
-
Page/Page column 39; 40, (2014/05/07)
The invention concerns a liquid pharmaceutical composition comprising: A Factor VIIa polypeptide; A buffering agent suitable for keeping pH in the range of from about 5.5 to about 8.5; and An active site stabilizing agent, which is a compound exhibiting a
FACTOR VIIA INHIBITOR
-
Paragraph 0200; 0201, (2014/04/03)
The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rheumatoid arthritis. Processes for preparing these inhibitors are also disclosed.
FACTOR VIIA INHIBITOR
-
Page/Page column 48, (2010/02/15)
The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders
